Apex Healthcare Bhd
will proceed with its original plan to invest in a China-based pharmaceutical company, but on a smaller scale.
In an announcement to Bursa Malaysia last Friday, the company said it would take up a 25% stake in Xiamen Maidiken Science & Technology Co Ltd (XMST) via a wholly-owned subsidiary for RM9.8mil.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
